Centiva Capital’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,724
| Closed | -$100K | – | 1292 |
|
|
2024
Q4 | $100K | Sell |
30,724
-9,276
| -23% | -$30.3K | ﹤0.01% | 1151 |
|
|
2024
Q3 | $154K | Sell |
40,000
-12,800
| -24% | -$49.3K | ﹤0.01% | 1364 |
|
|
2024
Q2 | $163K | Sell |
52,800
-1,300,080
| -96% | -$4.02M | ﹤0.01% | 1292 |
|
|
2024
Q1 | $3.49M | Sell |
1,352,880
-67,840
| -5% | -$175K | 0.09% | 64 |
|
|
2023
Q4 | $3.55M | Buy |
1,420,720
+349,015
| +33% | +$873K | 0.08% | 77 |
|
|
2023
Q3 | $2.18M | Buy |
+1,071,705
| New | +$2.18M | 0.05% | 182 |
|
|
2022
Q2 | – | Sell |
-300,000
| Closed | -$894K | – | 1195 |
|
|
2022
Q1 | $894K | Buy |
300,000
+270,500
| +917% | +$806K | 0.02% | 441 |
|
|
2021
Q4 | $115K | Sell |
29,500
-28,000
| -49% | -$109K | ﹤0.01% | 643 |
|
|
2021
Q3 | $247K | Buy |
+57,500
| New | +$247K | 0.02% | 668 |
|